Condition: Obesity and Obesity-related Medical Conditions · Obesity and Overweight · Obesity Prevention · Sponsor: Dr. Christopher McGowan
The purpose of this study is to evaluate the feasibility, safety, and tolerability of endoscopic selective gastric mucosal ablation (GMA) using argon plasma coagulation after sleeve gastrectomy. In this study, GMA will be performed on patients who have experienced weight regain following an initial successful response to sleeve gastrectomy.
This description comes directly from the study's public registry record.
Shannon Casey, MS · (919) 391-7843 · Shannon@trueyouweightloss.com
Chase Wooley, BS · (984) 345-2988 · Chase@trueyouweightloss.com
Always discuss trial participation with your own doctor first.
| True You Weight Loss | Cary, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06671119